|
AU759255B2
(en)
|
1998-01-29 |
2003-04-10 |
Amgen, Inc. |
PPAR-gamma modulators
|
|
US20080269265A1
(en)
|
1998-12-22 |
2008-10-30 |
Scott Miller |
Inhibition Of Raf Kinase Using Symmetrical And Unsymmetrical Substituted Diphenyl Ureas
|
|
DK1478358T3
(da)
|
2002-02-11 |
2013-10-07 |
Bayer Healthcare Llc |
Sorafenibtosylat til behandling af sygdomme kendetegnet ved unormal angiogenese
|
|
TW200410945A
(en)
|
2002-08-08 |
2004-07-01 |
Amgen Inc |
Vanilloid receptor ligands and their use in treatments"
|
|
DK2316831T3
(da)
|
2002-11-21 |
2013-06-10 |
Novartis Ag |
2-(Morpholin-4-yl)pyrimidiner som phosphotidylinositol (PI)-3-kinaseinhibitorer samt deres anvendelse ved behandling af cancer
|
|
US7202257B2
(en)
|
2003-12-24 |
2007-04-10 |
Deciphera Pharmaceuticals, Llc |
Anti-inflammatory medicaments
|
|
US7144911B2
(en)
|
2002-12-31 |
2006-12-05 |
Deciphera Pharmaceuticals Llc |
Anti-inflammatory medicaments
|
|
US7279576B2
(en)
|
2002-12-31 |
2007-10-09 |
Deciphera Pharmaceuticals, Llc |
Anti-cancer medicaments
|
|
US20050014753A1
(en)
|
2003-04-04 |
2005-01-20 |
Irm Llc |
Novel compounds and compositions as protein kinase inhibitors
|
|
US7504401B2
(en)
|
2003-08-29 |
2009-03-17 |
Locus Pharmaceuticals, Inc. |
Anti-cancer agents and uses thereof
|
|
KR101195801B1
(ko)
|
2004-06-18 |
2012-11-05 |
밀레니엄 파머슈티컬스 인코퍼레이티드 |
Xa 인자 억제제
|
|
GB0415364D0
(en)
|
2004-07-09 |
2004-08-11 |
Astrazeneca Ab |
Pyrimidine derivatives
|
|
WO2006031852A1
(en)
|
2004-09-13 |
2006-03-23 |
Amgen Inc. |
Vanilloid receptor ligands and their use in treatments
|
|
ATE502025T1
(de)
|
2004-10-19 |
2011-04-15 |
Compass Pharmaceuticals Llc |
Arylcarboxamide und ihre verwendung als antitumormittel
|
|
CA2575764A1
(en)
|
2004-10-27 |
2006-05-11 |
Neurogen Corporation |
Diaryl ureas as cb1 antagonists
|
|
CA2592118C
(en)
|
2004-12-23 |
2015-11-17 |
Deciphera Pharmaceuticals, Llc |
Urea derivatives as enzyme modulators
|
|
PL1836169T3
(pl)
|
2004-12-28 |
2012-07-31 |
Kinex Pharmaceuticals Llc |
Kompozycje i sposoby leczenia zaburzeń związanych z proliferacją komórek
|
|
US20060178388A1
(en)
|
2005-02-04 |
2006-08-10 |
Wrobleski Stephen T |
Phenyl-substituted pyrimidine compounds useful as kinase inhibitors
|
|
EP1871762A2
(en)
|
2005-04-18 |
2008-01-02 |
Neurogen Corporation |
Subtituted heteroaryl cb1 antagonists
|
|
US8188113B2
(en)
|
2006-09-14 |
2012-05-29 |
Deciphera Pharmaceuticals, Inc. |
Dihydropyridopyrimidinyl, dihydronaphthyidinyl and related compounds useful as kinase inhibitors for the treatment of proliferative diseases
|
|
US7897762B2
(en)
|
2006-09-14 |
2011-03-01 |
Deciphera Pharmaceuticals, Llc |
Kinase inhibitors useful for the treatment of proliferative diseases
|
|
US7790756B2
(en)
|
2006-10-11 |
2010-09-07 |
Deciphera Pharmaceuticals, Llc |
Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases
|
|
GB0625659D0
(en)
|
2006-12-21 |
2007-01-31 |
Cancer Rec Tech Ltd |
Therapeutic compounds and their use
|
|
WO2008140895A1
(en)
|
2007-04-20 |
2008-11-20 |
Deciphera Pharmaceuticals, Llc |
Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases
|
|
US8343966B2
(en)
|
2008-01-11 |
2013-01-01 |
Novartis Ag |
Organic compounds
|
|
BRPI0915105A2
(pt)
|
2008-06-13 |
2019-09-24 |
Novartis Ag |
composto de 2,4'-biripidinila como inibidores da proteína cinase d úteis para o tratamento de ia insuficiência cardíaca e cancer
|
|
CA2742007C
(en)
|
2008-10-29 |
2014-07-08 |
Deciphera Pharmaceuticals, Llc |
Cyclopropane amides and analogs exhibiting anti-cancer and anti-proliferative activities
|
|
EP2542536B1
(en)
|
2010-03-04 |
2015-01-21 |
Cellzome Limited |
Morpholino substituted urea derivatives as mtor inhibitors
|
|
BR112012027743A2
(pt)
|
2010-04-29 |
2017-03-14 |
Deciphera Pharmaceuticals Llc |
ciclopropil dicarboxamidas e análogos exibindo atividades anticâncer e antiproliferativas
|
|
EP2563773A1
(en)
|
2010-04-29 |
2013-03-06 |
Deciphera Pharmaceuticals, LLC |
Pyridone amides and analogs exhibiting anti-cancer and anti-proliferative activites
|
|
HK1202450A1
(zh)
|
2011-11-22 |
2015-10-02 |
Deciphera Pharmaceuticals, Llc. |
表現出抗癌和抗增殖活性的吡啶酮酰胺以及類似物
|
|
AR090151A1
(es)
|
2012-03-07 |
2014-10-22 |
Lilly Co Eli |
Compuestos inhibidores de raf
|
|
US9187474B2
(en)
|
2012-03-07 |
2015-11-17 |
Deciphera Pharmaceuticals, Llc |
Raf inhibitor compounds
|
|
US8461179B1
(en)
|
2012-06-07 |
2013-06-11 |
Deciphera Pharmaceuticals, Llc |
Dihydronaphthyridines and related compounds useful as kinase inhibitors for the treatment of proliferative diseases
|
|
US9242969B2
(en)
*
|
2013-03-14 |
2016-01-26 |
Novartis Ag |
Biaryl amide compounds as kinase inhibitors
|
|
US9193719B2
(en)
|
2013-03-15 |
2015-11-24 |
Deciphera Pharmaceuticals, Llc |
1,2,4-triazol-5-ones and analogs exhibiting anti-cancer and anti-proliferative activities
|
|
US9133183B2
(en)
|
2013-03-15 |
2015-09-15 |
Deciphera Pharmaceuticals, Llc |
Imidazolidinones and analogs exhibiting anti-cancer and anti-proliferative activities
|
|
US9012635B2
(en)
|
2013-03-15 |
2015-04-21 |
Deciphera Pharmaceuticals, Llc |
Pyridone amides and analogs exhibiting anti-cancer and anti-proliferative activities
|
|
CN105120864B
(zh)
|
2013-03-15 |
2017-05-17 |
德西费拉制药有限责任公司 |
表现出抗癌活性和抗增殖活性的2‑氨基嘧啶‑6‑酮及类似物
|
|
BR112015022263B1
(pt)
|
2013-03-15 |
2023-01-03 |
Deciphera Pharmaceuticals Llc |
N-acil-n-(piridin-2-il) uréias e análogos apresentando atividades anticâncer e antiproliferativas, seus usos, e composição farmacêutica
|
|
WO2014145029A2
(en)
|
2013-03-15 |
2014-09-18 |
Deciphera Pharmaceuticals, Llc |
N-acyl-n'-(pyridin-2-yl) ureas and analogs exhibiting anti-cancer and anti-proliferative activities
|
|
EA029981B1
(ru)
|
2013-08-27 |
2018-06-29 |
Бристол-Майерс Сквибб Компани |
Ингибиторы ido
|
|
US10329270B2
(en)
|
2013-10-21 |
2019-06-25 |
Merck Patent Gmbh |
Heteroaryl compounds as BTK inhibitors and uses thereof
|
|
WO2015059618A1
(en)
|
2013-10-22 |
2015-04-30 |
Glenmark Pharmaceuticals S.A. |
SUBSTITUTED PYRIMIDINE COMPOUNDS AS mPGES-1 INHIBITORS
|
|
US9457019B2
(en)
|
2013-11-07 |
2016-10-04 |
Deciphera Pharmaceuticals, Llc |
Methods for inhibiting tie-2 kinase useful in the treatment of cancer
|
|
US10266515B2
(en)
|
2013-12-30 |
2019-04-23 |
Lifesci Pharmaceuticals, Inc. |
Therapeutic inhibitory compounds
|
|
TN2016000270A1
(en)
|
2014-01-14 |
2017-10-06 |
Millennium Pharm Inc |
Heteroaryls and uses thereof.
|
|
JP6636014B2
(ja)
|
2014-09-12 |
2020-01-29 |
ノバルティス アーゲー |
Rafキナーゼ阻害剤としての化合物および組成物
|
|
WO2018104307A1
(en)
|
2016-12-09 |
2018-06-14 |
Bayer Pharma Aktiengesellschaft |
Aromatic sulfonamide derivatives and their use as anatagon i sts or negative allosteric modulators of p2x4
|
|
BR112019025346A2
(pt)
|
2017-05-30 |
2020-06-30 |
Deciphera Pharmaceuticals, Inc. |
uso de 1-[4-bromo-5-[1-etil-7-(metilamino)-2-oxo-1,2-dihidro-1,6-naftiridin-3-il]-2-fluorofenil]-3-fenilureia e análogos para o tratamento de cânceres associados a anormalidades genéticas no receptor alfa do fator de crescimento derivado de plaquetas
|
|
TW201940165A
(zh)
|
2018-01-29 |
2019-10-16 |
美商卡普勒斯療法有限責任公司 |
包含6員中心環的srebp抑制劑
|
|
KR102708177B1
(ko)
|
2018-01-31 |
2024-09-23 |
데시페라 파마슈티칼스, 엘엘씨. |
위장관 기질 종양의 치료를 위한 병용 요법
|
|
CN118903436A
(zh)
|
2018-01-31 |
2024-11-08 |
德西费拉制药有限责任公司 |
治疗肥大细胞增多症的组合疗法
|
|
CN112189012B
(zh)
|
2018-04-10 |
2024-02-13 |
神经孔疗法股份有限公司 |
作为pi3激酶和自噬途径的调节剂的三取代芳基和杂芳基衍生物
|
|
US11945803B2
(en)
|
2018-08-07 |
2024-04-02 |
Tosk, Inc. |
Modulators of RAS GTPase
|
|
SMT202500389T1
(it)
|
2018-12-28 |
2025-11-10 |
Deciphera Pharmaceuticals Llc |
Inibitori di csf1r per l'uso nel trattamento di tumori tenosinoviali a cellule giganti
|
|
JP2022525885A
(ja)
|
2019-03-22 |
2022-05-20 |
キネート バイオファーマ インク. |
Rafキナーゼの阻害剤
|
|
HUE065486T2
(hu)
|
2019-05-10 |
2024-05-28 |
Deciphera Pharmaceuticals Llc |
Fenilaminopirimidinamid autophágia inhibitorok és azok felhasználási eljárásai
|
|
HRP20231310T1
(hr)
|
2019-05-10 |
2024-02-02 |
Deciphera Pharmaceuticals, Llc |
Heteroarilaminopirimidin amidni inhibitori autofagije i postupci njihove primjene
|
|
EP4563150A3
(en)
*
|
2019-05-13 |
2025-07-23 |
Novartis AG |
New crystalline forms of n-(3-(2-(2-hydroxyethoxy)-6-morpholinopyridin-4-yl)-4-methvlphenyl)-2(trifluoromethyl) isonicotinamide as raf inhibitors for the treatment of cancer
|
|
BR112021022659A2
(pt)
|
2019-05-15 |
2022-03-29 |
Chemocentryx Inc |
Compostos triarílicos para o tratamento de doenças pd-l1
|
|
ES3072710T3
(en)
|
2019-06-17 |
2026-07-03 |
Deciphera Pharmaceuticals Llc |
Aminopyrimidine amide autophagy inhibitors and methods of use thereof
|
|
HRP20260411T1
(hr)
|
2019-08-12 |
2026-05-08 |
Deciphera Pharmaceuticals, Llc |
Ripretinib za liječenje gastrointestinalnih stromalnih tumora
|
|
US12691108B2
(en)
|
2019-08-12 |
2026-07-28 |
Deciphera Pharmaceuticals, Llc |
Methods for treating vascular malformations
|
|
AU2020371727B2
(en)
|
2019-10-24 |
2026-01-22 |
Pierre Fabre Medicament |
Inhibitors of RAF kinases
|
|
US20230046018A1
(en)
|
2019-12-06 |
2023-02-16 |
Medshine Discovery Inc. |
Biaryl compound as pan-raf kinase inhibitor
|
|
FI4084779T3
(fi)
|
2019-12-30 |
2024-12-16 |
Deciphera Pharmaceuticals Llc |
1-(4-bromi-5-(1-etyyli-7-(metyyliamino)-2-okso-1,2-dihydro-1,6-naftyridin-3-yyli)-2-fluorifenyyli)-3-fenyyliurean koostumuksia
|
|
BR112022015109A2
(pt)
|
2020-01-29 |
2022-11-08 |
Foghorn Therapeutics Inc |
Compostos e usos dos mesmos
|
|
CN115175902B
(zh)
|
2020-03-13 |
2024-07-26 |
郑州同源康医药有限公司 |
一类用作激酶抑制剂的化合物及其应用
|
|
WO2022060996A1
(en)
*
|
2020-09-18 |
2022-03-24 |
Kinnate Biopharma Inc. |
Inhibitors of raf kinases
|
|
TW202229239A
(zh)
|
2020-09-23 |
2022-08-01 |
日商武田藥品工業股份有限公司 |
作為ripk2抑制劑之3-(6-胺基吡啶-3-基)苯甲醯胺衍生物
|
|
US11377431B2
(en)
|
2020-10-12 |
2022-07-05 |
Kinnate Biopharma Inc. |
Inhibitors of RAF kinases
|
|
JP2023550638A
(ja)
|
2020-11-25 |
2023-12-04 |
デシフェラ・ファーマシューティカルズ,エルエルシー |
ウイルス感染症の処置に使用するための、vsp34阻害剤としてのモルホリノ誘導体
|
|
WO2022115546A1
(en)
|
2020-11-25 |
2022-06-02 |
Deciphera Pharmaceuticals, Llc |
Anti-viral activity of vps34 inhibitors
|
|
WO2022115558A1
(en)
|
2020-11-25 |
2022-06-02 |
Deciphera Pharmaceuticals, Llc |
Morpholino derivatives as vsp34 inhibitors for use in the treatment of a viral infection
|
|
EP4251156A1
(en)
|
2020-11-25 |
2023-10-04 |
Deciphera Pharmaceuticals, LLC |
Anti-viral activity of vps34 inhibitors
|
|
CN117083064A
(zh)
|
2020-11-25 |
2023-11-17 |
德西费拉制药有限责任公司 |
作为vps34抑制剂用于治疗病毒感染的吡啶基吡啶酮衍生物
|
|
WO2022115549A1
(en)
|
2020-11-25 |
2022-06-02 |
Deciphera Pharmaceuticals, Llc |
Anti-viral activity of vps34 inhibitors
|